Central Contact
Rare Disease / Clinical Research
Astellas Pharma Global Development
PI on 26 trials
ℹ
Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.
Report missing dataRare diseases treated or studied
Based on trial PI assignments and publication topics.
- Invasive candidiasis
- Mandibuloacral dysplasia
- Amyotrophic lateral sclerosis
- Adult-onset myasthenia gravis
- T-cell non-Hodgkin lymphoma
- Aspergillosis
- Autoimmune polyendocrinopathy
- Follicular lymphoma
- Alveolar soft tissue sarcoma
- C syndrome
- Vernal keratoconjunctivitis
- Meningococcal meningitis
- REN-related autosomal dominant tubulointerstitial kidney disease
- Macrophagic myofasciitis
- Genetic head and neck malformation
- Complication after organ transplantation
- Acute promyelocytic leukemia
Clinical trials (26)
Verify independently
Other specialists for Invasive candidiasis
Peers ranked by clinical-trial PI role, publications, and verification quality.
- Robert Krause, MDMedical University of Graz
- Laura Cox, PhDMundipharma Research Limited
- Shan-Chwen Chang, MDNational Taiwan University Hospital
- Hana Slepčanová, Mgr.University Hospital Ostrava
- Luigi PicaroGilead Sciences
- MJP van Wanrooy, PharmDUniversity Medical Center Groningen
- Taylor Sandison, MD MPHCidara TherapeuticsWA
- Jean-Francois TIMSIT, ProfessorAssistance Publique - Hôpitaux de Paris